Irina F. Sevrioukova

Picture of Irina F. Sevrioukova
Researcher, Molecular Biology and Biochemistry
School of Biological Sciences
M.D., School of Medicine, Moscow, Russia
PH.D., Institute of Biomedical Chemistry, Moscow, Russia
Phone: (949) 824-1953
Email: sevrioui@uci.edu
University of California, Irvine
3205 McGaugh Hall
Mail Code: 3900
Irvine, CA 92697
Research Interests
Structure/function of drug metabolizing enzymes, protein crystallography, rational drug design
Academic Distinctions
1993-1995 - Postdoctoral Fellowship, Robert Welch Foundation;

1997-2000 - Institutional and Individual Postdoctoral National Research Service Awards, NIH.
Appointments
Postdoctoral fellow, University of Texas Southwestern Medical Center, Dallas TX
Postdoctoral fellow, University of California, Irvine CA
Available Technologies
Publications
Sevrioukova IF. Structural basis for the diminished ligand binding and catalytic ability of fetal-specific CYP3A7. Int. J. Mol. Sci. 2021, 22(11), 5831.
Toupin N, Steinke SJ, Nadella S, Li A, Rohrabaugh TN Jr, Samuels ER, Turro C, Sevrioukova IF, Kodanko JJ. Photosensitive Ru(II) complexes as inhibitors of the major human drug metabolizing enzyme CYP3A4. J. Am. Chem. Soc. 2021, 143(24), 9191-9205
Samuels ER, Sevrioukova IF. Rational design of CYP3A4 inhibitors: A one-atom linker elongation in ritonavir-like compounds leads to a marked improvement in the binding strength. Int. J. Mol. Sci. 2021, 22(2) E852
Samuels ER, Sevrioukova IF. An increase in side-group hydrophobicity largely improves the potency of ritonavir-like inhibitors of CYP3A4. Bioorg & Med Chem 2020, 28(6) 115349.
Sevrioukova IF. Structural insights into the interaction of cytochrome P450 3A4 with suicide substrates: Mibefradil, azamulin and 6',7'-dihydroxybergamottin. Int. J. Mol. Sci. 2019, 20(17), pii: E4245.
Samuels ER, Sevrioukova I. Structure-activity relationships of rationally designed ritonavir analogs: Impact of side-group stereochemistry, headgroup spacing, and backbone composition on the Interaction with CYP3A4. Biochemistry. 2019, 58(15), 2077-2087.
Sevrioukova I. Interaction of human drug-metabolizing CYP3A4 with small inhibitory molecules. Biochemistry. 2019, 58(7), 930-939.
Samuels ER, Sevrioukova IF Inhibition of human CYP3A4 by rationally designed ritonavir-like compounds: Impact and interplay of the side group functionalities. Mol. Pharm. 2018, 15(1), 279-288.
I. Sevrioukova and T.L. Poulos "Structural basis for regiospecific midazolam oxidation by human cytochrome P450 3A4" (2017) PNAS 114, 486-491.
Complete List of Published Work at
https://www.ncbi.nlm.nih.gov/myncbi/1tutXnF23pnQn/bibliography/public/
Grants
NIH ES025767
Professional Societies
American Society for Biochemistry and Molecular Biology
Last updated
04/06/2022